Revenue and net profit saw strong year-over-year growth, supported by robust medical services and pharmacy segments. The company completed its IPO, distributed exceptional dividends, and recognized a significant gain from a land-for-fund transaction.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.